2022-12-02

Clinical Lab Products: The Future of Cervical Cancer Screening is Here

Molly Broache, Associate Director, Medical Affairs for US IDS discusses the future of cervical cancer screening

The future of cervical cancer screening is here. Featured in Clinical Lab Products, Associate Director of Medical Affairs Molly Broache notes that in today’s world where patients are catching up on missed screenings, adding pressure on already-pressured labs, it’s that much more important to take advantage of instruments and assays that do more and do better. The BD Onclarity HPV Assay is a perfect example with its cutting-edge approach to HPV testing.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

physician and patient
New Harris Poll Finds Women Want More Education on Sexually Transmitted Infections Testing and Treatment
BD released findings from a survey conducted by The Harris Poll that indicate a significant gap in women’s knowledge about the primary causes of cervical cancer as well as the most effective means of prevention.
Cervical Cancer | News & Updates
Press Release: New Harris Poll Reveals Significant Gaps in Women's Knowledge About Cervical Cancer
Contemporary Obgyn: Not all HPV genotypes pose the same risk for disease
Cervical Cancer | News & Updates
Contemporary OB/GYN: Not all HPV genotypes pose the same risk for disease